Recently, Patel et al. [4] demonstrated that the expression of tumor-derived mutant p53-R273H caused a decrease in ECRG2 protein expression in RKO p53−/− colon cancer cells, which was previously shown to compromise the transcriptional activation function of wild-type p53 [53,54]. The gene discussed is TP53; the disease is neoplasm.